Zometa

Description

Zometa is a bone resorption inhibitor, belongs to the class of highly effective bisphosphonates that have a selective effect on bone tissue.

It has direct antitumor properties, ensuring effectiveness in bone metastases.

Zometa is used in the presence of osteolytic, osteosclerotic and mixed bone metastases of solid tumors, for the treatment of hypercalcemia caused by a malignant tumor.

Active ingredient: zoledronic acid

Prescription medicine

Store at a temperature of 2-8 degrees